Canada Life’s Exar Corporation EXAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-62,778
Closed -$816K 2577
2017
Q1
$816K Buy
62,778
+3,953
+7% +$42.4K ﹤0.01% 1576
2016
Q4
$635K Hold
58,825
﹤0.01% 1641
2016
Q3
$547K Sell
58,825
-5,551
-9% -$48.4K ﹤0.01% 1641
2016
Q2
$518K Buy
64,376
+54,876
+578% +$367K ﹤0.01% 1639
2016
Q1
$55K Hold
9,500
﹤0.01% 2090
2015
Q4
$58K Hold
9,500
﹤0.01% 2088
2015
Q3
$57K Hold
9,500
﹤0.01% 2038
2015
Q2
$93K Buy
+9,500
New +$99.3K ﹤0.01% 1924

Canada Life's EXAR Position: Q2 2017 in Review

Canada Life sold out of Exar Corporation (EXAR) in Q2 2017, closing a stake of 62,778 shares — an estimated $816K sold.

Canada Life first reported a position in EXAR in Q2 2015 and held it in 8 quarters. The position peaked at $816K in Q1 2017. 0 funds tracked by Wall St. Rank hold EXAR as of Q2 2017.

  • Canada Life reported no remaining Exar Corporation position as of Q2 2017 after selling out during the quarter.
  • Canada Life sold 62,778 Exar Corporation shares in Q2 2017, an estimated $816K.
  • Canada Life first reported a position in Exar Corporation in Q2 2015 and held it in 8 quarters.
  • Canada Life's Exar Corporation position peaked at $816K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Exar Corporation as of Q2 2017.

Based on Canada Life's 13F filing for Q2 2017, filed 27 Jul 2017.